These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25907173)

  • 1. A case of lacosamide-induced hepatotoxicity.
    Sunwoo JS; Byun JI; Lee SK
    Int J Clin Pharmacol Ther; 2015 Jun; 53(6):471-3. PubMed ID: 25907173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early monitoring for detection of antituberculous drug-induced hepatotoxicity.
    Lee CM; Lee SS; Lee JM; Cho HC; Kim WS; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ
    Korean J Intern Med; 2016 Jan; 31(1):65-72. PubMed ID: 26767859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical stabilisation with lacosamide of mood disorder comorbid with PTSD and fronto-temporal epilepsy.
    Cuomo I; Kotzalidis GD; De Filippis S
    Acta Biomed; 2017 Aug; 88(2):185-189. PubMed ID: 28845834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sinus node dysfunction: an adverse effect of lacosamide.
    Chinnasami S; Rathore C; Duncan JS
    Epilepsia; 2013 Jun; 54(6):e90-3. PubMed ID: 23360388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.
    Pasha I; Kamate M; Didagi SK
    Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
    Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
    Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
    Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P
    Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First case of lacosamide-induced psychosis.
    Chatzistefanidis D; Karvouni E; Kyritsis AP; Markoula S
    Clin Neuropharmacol; 2013; 36(1):27-8. PubMed ID: 23334072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lacosamide-induced rash.
    Koubeissi MZ; Vismer M; Ehrlich A
    Epileptic Disord; 2014 Sep; 16(3):380-3. PubMed ID: 25035958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis induced by Teucrium viscidum.
    Poon WT; Chau TL; Lai CK; Tse KY; Chan YC; Leung KS; Chan YW
    Clin Toxicol (Phila); 2008 Nov; 46(9):819-22. PubMed ID: 18608288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of less frequent monitoring of liver transaminases levels in rheumatic patients treated with low-dose methotrexate.
    Khabbazi A; Kolahi S; Dastgiri S; Hajialiloo M; Nazeri M; Nazeri L; Sheikholeslami Salmasi A; Gader S; Bak Mohammad Zadeh S; Ghasemi A; Poormohammad A
    Int J Rheum Dis; 2014 Jul; 17(6):646-52. PubMed ID: 24965662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose.
    Wong A; Sivilotti ML; Dargan PI; Wood DM; Greene SL
    Clin Toxicol (Phila); 2015; 53(8):807-14. PubMed ID: 26175095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacosamide intoxication in attempted suicide.
    Bauer S; David Rudd G; Mylius V; Hamer HM; Rosenow F
    Epilepsy Behav; 2010 Apr; 17(4):549-51. PubMed ID: 20171144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: a pharmacodynamic interaction?
    Novy J; Patsalos PN; Sander JW; Sisodiya SM
    Epilepsy Behav; 2011 Jan; 20(1):20-3. PubMed ID: 21056937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced liver injury: results from the hospital-based Berlin Case-Control Surveillance Study.
    Douros A; Bronder E; Andersohn F; Klimpel A; Thomae M; Sarganas G; Kreutz R; Garbe E
    Br J Clin Pharmacol; 2015 Jun; 79(6):988-99. PubMed ID: 25444550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone hepatotoxicity in the context of the metabolic syndrome and right-sided heart failure.
    Mattar W; Juliar B; Gradus-Pizlo I; Kwo PY
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):419-23. PubMed ID: 20076813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures.
    Beydoun A; D'Souza J; Hebert D; Doty P
    Expert Rev Neurother; 2009 Jan; 9(1):33-42. PubMed ID: 19102666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
    Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
    Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures.
    Fountain NB; Krauss G; Isojarvi J; Dilley D; Doty P; Rudd GD
    Epilepsia; 2013 Jan; 54(1):58-65. PubMed ID: 22708895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac sodium channel blockade after an intentional ingestion of lacosamide, cyclobenzaprine, and levetiracetam: Case report.
    Chua-Tuan JL; Cao D; Iwanicki JL; Hoyte CO
    Clin Toxicol (Phila); 2015 Jul; 53(6):565-8. PubMed ID: 25951877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.